Vulvodynia and the possibility of its management

Czech version

Authors: J. Kestřánek ¹; V. Matula ¹; V. Pidrman ²; R. Taláb ³; P. Jílek ⁴; V. Buchta ^4,5; J. Špaček ¹
Authors‘ workplace: Klinika porodnictví a gynekologie, Fakultní nemocnice a LF UK v Hradci Králové, přednosta doc. MUDr. J. Tošner, CSc. ¹; Privátní psychiatrická ambulance Galenus, Hradec Králové, doc. MUDr. V. Pidrman, Ph. D. ²; Neurologická klinika, Fakultní nemocnice a LF UK v Hradci Králové, přednosta MUDr. R. Taláb, CSc. ³; Katedra biologických a lékařských věd, Farmaceutická fakulta UK, vedoucí Pharm. Dr. P. Jílek, CSc. ⁴; Ústav klinické mikrobiologie, Fakultní nemocnice a LF UK v Hradci Králové, přednosta doc. RNDr. V. Buchta, CSc. ⁵
Published in: Ceska Gynekol 2010; 75(6): 521-526

Overview

Objective:
A study of vulvodynia and the possibility of its management.

Subject:
Original study.

Setting:
Department of Obstetrics and Gynecology, Teaching Hospital and Medical Faculty Hradec Králové, Charles University, Prague.

Department of Neurology, Teaching Hospital and Medical Faculty Hradec Králové, Charles University, Prague.

Outpatient psychiatric department Galenus, Hradec Králové.

Department of Clinical Microbiology, Teaching Hospital and Medical Faculty Hradec Králové, Charles University, Prague.

Department of Biological and Medical Sciences, Faculty of Pharmacy Hradec Králové, Charles University, Prague.

Methods:
Analysis and discussion focused on our experience in a long time follow-up of patients with chronic vulvovaginal discomfort and vulvodynia.

Conclusion:
Especially the management of indolent form of vulvodynia would be taken into consideration of idiopathic origin and problematic management. Our study emphasizes the necessity of individual approach. The goal of therapy in this most problematic form is the improving of the actual quality of life. In the case of idiopathic forms of vulvodynia.

Key words:
vulvodynia, chronic vulvovaginal discomfort, treatment, quality of life.

Sources

1. Bachmann, GA., Rosen, R., Pinn, VW., et al. Vulvodynia: a state-of-the-art consensus on definitions, diagnosis and management. J Reprod Med, 2006, 51, p. 447-456.

2. Bertolasi, L., Frasson, E., Cappelletti, JY., et al. Botulinum neurotoxin type A injections for vaginismus secondary to vulvar vestibulitis syndrome. Obstet Gynecol, 2009, 114, p. 1008-1016.

3. Boardman, LA., Cooper, AS., Blais, LR., et al. Topical gabapentin in the treatment of localized and generalized vulvodynia. Obstet Gynecol, 2008, 112, p. 579-585.

4. Bohm-Starke, N., Johannesson, U., Hilliges, M., et al. Decreased mechanical pain threshold in the vestibular mucosa of women using oral contraceptives: a contributing factor in vulvar vestibulitis? J Reprod Med, 2004, 49, p. 888-892.

5. Bouček, J., Pidrman, V. Psychofarmaka v medicíně. Praha: Grada Publishing, 2005, 286 s.

6. Bouchard, C., Brisson, J., Fortier, M., et al. Use of oral contraceptive pills and vulvar vestibulitis: a case-control study. Am J Epidemiol, 2002, 156, p. 254-261.

7. Brown, CS., Wan, J., Bachmann, G., et al. Self-management, amitriptyline, and amitripyline plus triamcinolone in the management of vulvodynia. J Womens Health (Larchmt.), 2009, 18, p. 163-169.

8. Eva, LJ., MacLean, AB., Reid, WM., et al. Estrogen receptor expression in vulvar vestibulitis syndrome. Am J Obstet Gynecol, 2003, 189, p. 458-461.

9. Eva, LJ., Narain, S., Orakwue, CO., et al. Is modified vestibulectomy for localized provoked vulvodynia an effective long-term treatment? A follow-up study. J Reprod Med, 2008, 53, p. 435-440.

10. Gelder, MG., Lopez-Ibor, JJ., Andreasen, NC. New Oxford textbook of psychiatry. New York: Oxford University Press, 2003, p. 2432.

11. Goldstein, AT., Marinoff, SC., Haefner, HK. Vulvodynia: strategies for treatment. Clin Obstet Gynecol, 2005, 48, p. 769-785.

12. Gunter, J. Vulvodynia: new thoughts on a devastating condition. ObstetGynecol Surv, 2007, 62, p. 812-819.

13. Gunter, J., Brewer, A., Tawfik, O. Botulinum toxin a for vulvodynia: a case report. J Pain, 2004, 5, p. 238-240.

14. Haefner, HK. Critique of new gynecologic surgical procedures: surgery for vulvar vestibulitis. Clin Obstet Gynecol, 2000, 43, p. 689-700.

15. Haefner, HK., Collins, ME., Davis, GD., et al. The vulvodynia guideline. J Low Genit Tract. Dis, 2005, 9, p. 40-51.

16. Harlow, BL., Abenhaim, HA., Vitonis, AF., Harnack, L. Influence of dietary oxalates on the risk of adult-onset vulvodynia. J Reprod Med, 2008, 53, p. 171-178.

17. Harris, G., Horowitz, B., Borgida, A. Evaluation of gabapentin in the treatment of generalized vulvodynia, unprovoked. J Reprod Med, 2007, 52, p. 103-106.

18. Jensen, JT., Wilder, K., Carr, K., et al. Quality of life and sexual function after evaluation and treatment at a referral center for vulvovaginal disorders. Am J Obstet Gynecol, 2003, 188, p. 1629-1635.

19. Kestřánek, J., jun., Buchta, V., Špaček, J., et al. Problematika vulvovaginálního dyskomfortu z hlediska mezioborové spolupráce. Epidemiol Mikrobiol Imunol, 2008, 57, s. 23-27.

20. Koleta, F. Vulvodynia. In: Infekce a zánět v gynekologii a porodnictví. Praha: Grada Publishing, 1995, s. 25.

21. Lynch, PJ. Vulvodynia as a somatoform disorder. J Reprod Med, 2008, 53, p. 390-396.

22. Morin, C., Bouchard, C., Brisson, J., et al. Human papillomaviruses and vulvar vestibulitis. Obstet Gynecol, 2000, 95, p. 683-687.

23. Petersen, CD., Lundvall, L., Kristensen, E., Giraldi, A. Vulvodynia. Definition, diagnosis and treatment. Acta Obstet Gynecol Scand, 2008, 87, p. 893-901.

24. Pidrman, V. Deprese žen. Depresivní onemocnění širší pohled. Praha: Maxdorf, 2004, s. 84-92.

25. Pidrman, V. Žena a poruchy nálady. Praha: Galén, 2006, s. 32.

26. Reed, BD. Vulvodynia: diagnosis and management. Am Fam Physician, 2006, 73, p. 1231-1238.

27. Reed, BD., Haefner, HK., Cantor, L. Vulvar dysesthesia (vulvodynia). A follow-up study. J Reprod Med, 2003, 48, p. 409‑416.

28. Reed, BD., Haefner, HK., Sen, A., Gorenflo, DW. Vulvodynia incidence and remission rates among adult women: a 2-year follow-up study. Obstet Gynecol, 2008, 112, p. 231-237.

29. Sadownik, LA. Clinical profile of vulvodynia patients. A prospective study of 300 patients. J Reprod Med , 2000, 45, p. 679-684.

30. Špaček, J., Buchta, V., Jílek, P., Förstl, M. Clinical aspects and luteal phase assessment in patients with recurrent vulvovaginal candidiasis. Eur J Obstet Gynecol Reprod Biol, 2007, 131, p. 198‑202

31. Updike, GM., Wiesenfeld, HC. Insight into the treatment of vulvar pain: a survey of clinicians. Am J Obstet Gynecol, 2005, 193, p. 1404-1409.

32. Yoon, H., Chung, WS., Shim, BS. Botulinum toxin A for the management of vulvodynia. Int J Impot Res, 2007, 19, p. 84-87.

33. Zolnoun, DA., Hartmann, KE., Steege, JF. Overnight 5% lidocaine ointment for treatment of vulvar vestibulitis. Obstet Gynecol, 2003, 102, p. 84-87.